News Highlights: Top Company News of the Day
October 26 2021 - 1:15AM
Dow Jones News
Chinese Developer Modern Land Fails to Repay $250 Million U.S. Dollar Bond
The Hong Kong-listed real-estate company had previously sought
to extend the bond's due date.
Facebook Posts Slower Sales Growth With Apple Privacy Policy
The social-media giant's primary revenue source saw slower
growth in the first full quarter since Apple required apps to ask
users whether they want to be tracked.
Judge Declines to Pause Talc Litigation Against Johnson & Johnson
But LTL Management, a J&J subsidiary, will get another
chance to stop litigation against its parent company in early
November.
Jeff Bezos' Blue Origin Pursues Private Space Station
The space company said it would help to build a facility, part
of a bet that many future orbital facilities will be privately
owned and operated.
Crown Can Keep Operating Melbourne Casino
Australian casino operator Crown Resorts engaged in illegal and
dishonest behavior but can keep operating its marquee casino in
Melbourne for now, a royal commission in Victoria state has
found.
Silver Lake Heads Back to Market As Tech Fundraising Swells
Investors say they expect the new fund to target at least as
much as the $20 billion flagship fund the tech-focused
private-equity firm announced in January.
PayPal Abandons Pinterest Takeover After Its Shareholders Balk
U.S. payments company PayPal Holdings said it isn't currently
pursuing a deal for social-media platform Pinterest, days after
media reports that the companies were in early talks for a
multibillion-dollar deal.
Comscore Names New CFO as It Looks to Boost Revenue
Jon Carpenter is set to join the company from privately held
Publishers Clearing House next month.
Tesla Surpasses $1 Trillion in Market Value as Hertz Orders 100,000 Vehicles
Hertz's major bulk purchase could help Tesla get more of its
cars into the hands of mainstream consumers. Tesla shares surged on
the news.
Moderna Covid-19 Vaccine Data Shows Strong Response in Children
Moderna said it would submit the results from an interim study
to health regulators in the U.S., Europe and elsewhere in seeking
authorization for 6- to 11-year-olds.
(END) Dow Jones Newswires
October 26, 2021 01:00 ET (05:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.